Latest Period
Q1 2026
Security Snapshot
Scilex Holding Co - Common Stock, par value $0.0001 per share (SCLX) Institutional Ownership
CUSIP: 80880W205
13F Institutional Holders and Ownership History from Q2 2024 to Q1 2026
Institutions Reporting
69
Shares (Excl. Options)
871,717
Price
$6.66
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- SCLX on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 871,717
- Total 13F value
- $5,805,880
- Portfolio coverage rank
- 0%
- Share change
- -259,625
- Value change
- -$2,086,248
- Number of holders
- 69
- Shares outstanding
- 8,928,776
- SEC-reported price per share
- $7.21
- Insider filing price
- $7.21
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- SCLX - Scilex Holding Co - Common Stock, par value $0.0001 per share is tracked under CUSIP 80880W205.
- 69 institutions reported positions in Q1 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 78 to 69 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $13,661,197 to $5,805,880.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 69 institutions filings for Q1 2026.
Security key
80880W205
Latest holder period
Q1 2026
13F holders
69
13D/G owners
2
CIK / CUSIP context first
Open Q1 2026 holders
SCLX full holder history
Scilex Holding Co SEC filings
Scilex Holding Co company facts
Scilex Holding Co insider transactions
Scilex Holding Co 13D/G history
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 80880W205:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
SCLX
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 8.6% | $31,008,000 | 4,800,000 | Armistice Capital, LLC | 30 Jun 2025 | |||
| ORAMED PHARMACEUTICALS INC. | 4.9% | -50% | $5,438,249 | -$4,921,820 | 437,510 | -48% | Oramed Pharmaceuticals Inc. | 31 Dec 2025 |
As of 31 Mar 2026, 69 institutional investors reported holding 871,717 shares of Scilex Holding Co - Common Stock, par value $0.0001 per share (SCLX). This represents 9.8% of the company’s total 8,928,776 outstanding shares.
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
8
Latest
Q1 2026
Rows shown
1-8 of 8
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 871,717 | $5,805,880 | -$2,086,248 | $6.66 | 69 |
| 2025 Q4 | 1,119,739 | $13,661,197 | +$3,630,948 | $12.20 | 78 |
| 2025 Q3 | 759,753 | $14,960,373 | +$3,238,244 | $19.68 | 79 |
| 2025 Q2 | 619,696 | $3,649,745 | +$3,564,555 | $5.89 | 63 |
| 2025 Q1 | 42,004 | $10,442 | +$10,434 | $0.25 | 4 |
| 2024 Q4 | 19 | $8 | $0.42 | 1 | |
| 2024 Q3 | 19 | $18 | $0.95 | 1 | |
| 2024 Q2 | 19 | $37 | +$37 | $1.95 | 1 |